New Medicine Development: Big Investors

Biopharma companies are crabbing up their drug research & development spending after staying stable all the way through last couple of years. According to industry sources, research & development investments will top $136 billion in 2013, up from $ 134 billion (2012); also the R&D expenditures estimated to exceed ($ 149 billion) by 2017.


| |
1 Star2Star3 Star4 Star5Star (1 votes, average: 5.00 out of 5)
Loading...

Add a Comment